ArticlePloS one2025

Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.

Barbara A Friedland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.